All lobbying filings

Centene Corporation

Centene Corporation filed a Q3 report for Centene Corporation on October 20, 2026.

Lobbying for Centene Corporation

As filed: CENTENE CORPORATION for CENTENE CORPORATION.

All filings by Centene Corporation · Everything Centene Corporation has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Expenses

$1,120,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

H.R. 4710, No Surprises Act Enforcement Act, including provisions related to the current No Surprises Act enforcement processes. S. 2355, Patients Deserve Price Tags Act, including provisions related to the hold-harmless of insurers. Issues and data related to marketplace enrollment.

Medicare/Medicaid

Issues related to efforts to improve prior authorization processes. Issues related to Medicare Part D.

Bills named in this filing 2

H.R. 4710
No Surprises Act Enforcement Act
S. 2355
Patients Deserve Price Tags Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.